Robot-assisted Versus Open Lateral Pancreaticojejunostomy for the Treatment of Symptomatic Chronic Pancreatitis (PANACOTTA)
NCT ID: NCT07109180
Last Updated: 2025-08-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
28 participants
INTERVENTIONAL
2025-04-16
2026-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Minimally Invasive Robot-assisted and Laparoscopic Distal Pancreatectomy in a Pan-European Registry
NCT06160154
Endotherapy and/or Extracorporeal Shockwave Lithotripsy for Painless Chronic Pancreatitis
NCT07074379
A Pan-European Study on Minimally Invasive Versus Open Pancreatoduodenectomy in High-volume Centers
NCT03172572
Effectiveness of Endorotor PED® System Versus Conventional Endoscopic Techniques for the Management of Walled-off Pancreatic Necrosis in Acute Necrotizing Pancreatitis: Randomized Single-blinded Controlled Superiority Trial and Cost-utility Analysis
NCT07253350
Laparotomy Versus Percutaneous Puncture in Patients With Abdominal Compartment Syndrome During Acute Pancreatitis
NCT00793715
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Robot-assisted lateral pancreaticojejunostomy
Robot-assisted lateral pancreaticojejunostomy
Robot-assisted
Open lateral pancreaticojejunostomy
Open lateral pancreaticojejunostomy
Open surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Robot-assisted lateral pancreaticojejunostomy
Robot-assisted
Open lateral pancreaticojejunostomy
Open surgery
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Indication for (extended or partial) lateral pancreaticojejunostomy as agreed during multidisciplinary team meeting based on symptomatic chronic pancreatitis (i.e. morphine dependent pain or recurrent acute flares of pancreatitis, at least 3 episodes per year) and a dilated pancreatic duct of ≥ 5 mm, with a non-enlarged pancreatic head \< 40 mm
* Confirmed CP, according to the M-ANNHEIM diagnostic Criteria24
* Eligible for both an robot-assisted and open approach
* Obtained written informed consent
Exclusion Criteria
* ASA classification ≥ 4
* Other painful conditions aside from CP, with pain difficult to discriminate from CP pain
* Prior pancreatic surgery
* Pregnancy
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St. Antonius Hospital
OTHER
Erasmus Medical Center
OTHER
Maastricht University Medical Center
OTHER
Universitätsklinikum Hamburg-Eppendorf
OTHER
University Medical Center Groningen
OTHER
Onze Lieve Vrouwe Gasthuis
OTHER
Catharina Ziekenhuis Eindhoven
OTHER
Radboud University Medical Center
OTHER
Medisch Spectrum Twente
OTHER
Leiden University Medical Center
OTHER
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
M.G. Besselink
M.G. Besselink
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
M.G. Besselink, Amsterdam UMC
Role: PRINCIPAL_INVESTIGATOR
prof. dr.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Amsterdam UMC
Amsterdam, , Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL87297.018.24
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.